sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
CTNM
Updated 10/6/2026, 8:26 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics, Inc. | Sale | $41,142 | Stengone Carmine N. CEO and President, Director | 2,500 sh | at $16.46 | Filed Sep 8, 6:08 PM ET | Filing | |
| CTNM Contineum Therapeutics, Inc. | Sale | $40,029 | Stengone Carmine N. CEO and President, Director | 2,500 sh | at $16.01 | Filed Aug 3, 6:14 PM ET | Filing | |
| CTNM Contineum Therapeutics, Inc. | Sale | $16,640 | Lorrain Daniel S. Chief Scientific Officer | 1,040 sh | at $16.00 | Filed Jul 10, 5:20 PM ET | Filing | |
| CTNM Contineum Therapeutics, Inc. | Sale | $40,000 | Stengone Carmine N. CEO and President, Director | 2,500 sh | at $16.00 | Filed Jul 8, 6:49 PM ET | Filing |